Fred Hutchinson Cancer Research

Seattle, Washington 98109-1024

0 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia, Grade B aGVHD, Grade C aGVHD, Grade D aGVHD, Neoplasms, Refractory Multiple Myeloma, Relapsed Multiple Myeloma

Studies at this site

• Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors — Running, not enrolling
• A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma — Completed
• A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD) — Completed
• Study of AMV564 in Patients With AML — Completed